P-glycoprotein expression in brain tumors - PubMed (original) (raw)
P-glycoprotein expression in brain tumors
J W Henson et al. J Neurooncol. 1992 Sep.
Abstract
Overexpression of P-glycoprotein (P-gp) in cancer cells can result in resistance to several chemotherapy agents (multidrug resistance) including doxorubicin and vincristine. The drugs to which resistance develops also penetrate the blood brain barrier poorly. P-gp expression in brain capillary endothelial cells suggests that P-gp may restrict drug entry into brain tumors and thus be another mechanism of drug resistance. To seek evidence for either of these roles in the drug resistance of brain tumors, we examined the location of expression of P-gp in 49 brain tumors, using an anti-P-gp mouse monoclonal antibody and immunohistochemistry. P-gp expression was observed in tumor cells of two glioblastomas and a meningeal sarcoma but not in low-grade primary or metastatic tumors. In low-grade primary tumors, P-gp was present in all vascular endothelial cells. In the vascular endothelial cells of anaplastic primary brain tumors and brain metastases, P-gp expression was heterogeneous or absent. These findings are consistent with a role for P-gp in the resistance of some brain tumors to chemotherapy agents.
Similar articles
- Drug resistance-associated factors in primary and secondary glioblastomas and their precursor tumors.
Tews DS, Nissen A, Külgen C, Gaumann AK. Tews DS, et al. J Neurooncol. 2000 Dec;50(3):227-37. doi: 10.1023/a:1006491405010. J Neurooncol. 2000. PMID: 11263502 - P-glycoprotein as the drug efflux pump in primary cultured bovine brain capillary endothelial cells.
Tsuji A, Terasaki T, Takabatake Y, Tenda Y, Tamai I, Yamashima T, Moritani S, Tsuruo T, Yamashita J. Tsuji A, et al. Life Sci. 1992;51(18):1427-37. doi: 10.1016/0024-3205(92)90537-y. Life Sci. 1992. PMID: 1357522 - Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites.
Cordon-Cardo C, O'Brien JP, Casals D, Rittman-Grauer L, Biedler JL, Melamed MR, Bertino JR. Cordon-Cardo C, et al. Proc Natl Acad Sci U S A. 1989 Jan;86(2):695-8. doi: 10.1073/pnas.86.2.695. Proc Natl Acad Sci U S A. 1989. PMID: 2563168 Free PMC article. - Does P-glycoprotein play a role in clinical resistance of malignant astrocytoma?
Ashmore SM, Thomas DG, Darling JL. Ashmore SM, et al. Anticancer Drugs. 1999 Nov;10(10):861-72. doi: 10.1097/00001813-199911000-00001. Anticancer Drugs. 1999. PMID: 10630353 Review. - P-glycoprotein-mediated efflux transport of anticancer drugs at the blood-brain barrier.
Tsuji A. Tsuji A. Ther Drug Monit. 1998 Oct;20(5):588-90. doi: 10.1097/00007691-199810000-00024. Ther Drug Monit. 1998. PMID: 9780140 Review.
Cited by
- The Application of Nanotechnology for the Diagnosis and Treatment of Brain Diseases and Disorders.
Ngowi EE, Wang YZ, Qian L, Helmy YASH, Anyomi B, Li T, Zheng M, Jiang ES, Duan SF, Wei JS, Wu DD, Ji XY. Ngowi EE, et al. Front Bioeng Biotechnol. 2021 Mar 2;9:629832. doi: 10.3389/fbioe.2021.629832. eCollection 2021. Front Bioeng Biotechnol. 2021. PMID: 33738278 Free PMC article. Review. - Computational model of brain endothelial cell signaling pathways predicts therapeutic targets for cerebral pathologies.
Gorick CM, Saucerman JJ, Price RJ. Gorick CM, et al. J Mol Cell Cardiol. 2022 Mar;164:17-28. doi: 10.1016/j.yjmcc.2021.11.005. Epub 2021 Nov 16. J Mol Cell Cardiol. 2022. PMID: 34798125 Free PMC article. - Examination of blood-brain barrier (BBB) integrity in a mouse brain tumor model.
On NH, Mitchell R, Savant SD, Bachmeier CJ, Hatch GM, Miller DW. On NH, et al. J Neurooncol. 2013 Jan;111(2):133-43. doi: 10.1007/s11060-012-1006-1. Epub 2012 Nov 27. J Neurooncol. 2013. PMID: 23184143 Free PMC article. - Prognostic value of immunoexpression of the chemoresistance-related proteins in ependymomas: an analysis of 76 cases.
Korshunov A, Sycheva R, Timirgaz V, Golanov A. Korshunov A, et al. J Neurooncol. 1999;45(3):219-27. doi: 10.1023/a:1006369829576. J Neurooncol. 1999. PMID: 10845392
References
- Acta Neuropathol. 1982;57(2-3):121-9 - PubMed
- Cancer Res. 1979 Jun;39(6 Pt 1):2200-3 - PubMed
- Science. 1989 Sep 8;245(4922):1066-73 - PubMed
- J Natl Cancer Inst. 1989 Jan 18;81(2):116-24 - PubMed
- Cancer Res. 1989 Jun 15;49(12):3209-14 - PubMed
MeSH terms
Substances
LinkOut - more resources
Medical
Miscellaneous